Search Results 991-1000 of 16780 for astragalus dosage

  1. Clinical trials - Oncology (Medical)

    The purpose of this study is to identify the side effects and best dose of abemaciclib when given together with olaparib in treating patients with ovarian ...

  2. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

    ... dose of cabozantinib or sunitinib. The subject is ≥ 18 years old on the day of consent. The subject has an Eastern Cooperative Oncology Group (ECOG) ...

  3. Hodgkin Clinical Trials - Mayo Clinic Research

    This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...

  4. Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies - Mayo Clinic

    to the first dose of study treatment and withheld until 14 days after the last dose of. AZD0466; concurrent anti-coagulation therapy, including aspirin and ...

  5. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    Resistance to HU is defined at a dose ≥ 2 g/day or a maximum tolerated dose < 2 g/day resulting in at least one of the following: Need for phlebotomy to ...

  6. Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma - Mayo Clinic

    The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

  7. Clinical trials - Oncology (Medical)

    Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a ...

  8. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Chronic Myelomonocytic Leukemia) - Mayo Clinic

    Stage 1 will consist of a period in which several doses of SL-401 are evaluated. ... dose or maximum tested dose in which multiple dose-limiting toxicities ...

  9. Gastroenterology and Hepatology - Clinical trials

    A Study of Intratumoral Injection of Autologous Dendritic Cells after High-Dose Conformal External Beam Radiotherapy in Patients with Unresectable Liver Cancer.

  10. Obstetrics and Gynecology - Clinical trials

    ... dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma. Patient ...